PDS Biotechnology Corporation Share Price
Equities
PDSB
US70465T1079
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.27 USD | +0.31% | +23.63% | -34.21% |
28/03 | B. Riley Securities Adjusts PDS Biotechnology's Price Target to $11 From $14, Maintains Buy Rating | MT |
27/03 | Empire Metals targets key milestones in Australia | AN |
Sales 2024 * | - | Sales 2025 * | 275K 22.94M | Capitalization | 120M 10B |
---|---|---|---|---|---|
Net income 2024 * | -51M -4.25B | Net income 2025 * | -63M -5.25B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 436 x |
P/E ratio 2024 * |
-2.2
x | P/E ratio 2025 * |
-2.03
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.33% |
Latest transcript on PDS Biotechnology Corporation
1 day | +0.31% | ||
1 week | +23.63% | ||
Current month | -17.42% | ||
1 month | -17.42% | ||
3 months | -40.44% | ||
6 months | -18.66% | ||
Current year | -34.21% |
Managers | Title | Age | Since |
---|---|---|---|
Frank Bedu-Addo
FOU | Founder | 59 | 15/19/15 |
Director of Finance/CFO | 55 | 04/12 | |
David Schaaf
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Glover
CHM | Chairman | 65 | 02/19/02 |
Otis Brawley
BRD | Director/Board Member | 64 | 03/20/03 |
Richard Sykes
BRD | Director/Board Member | 79 | 01/19/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 3.27 | +0.31% | 415,645 |
25/24/25 | 3.26 | +0.31% | 421,721 |
24/24/24 | 3.25 | +1.56% | 447,158 |
23/24/23 | 3.2 | +7.02% | 990,581 |
22/24/22 | 2.99 | +13.04% | 684,226 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.21% | 120M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.79% | 22.15B | |
-17.37% | 21.02B | |
-8.42% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- PDSB Stock